An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer.
Saved in:
| Title: | An oncogenic KRAS transcription program activates the RHOGEF ARHGEF2 to mediate transformed phenotypes in pancreatic cancer. |
|---|---|
| Authors: | Kent OA; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada., Sandí MJ; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada., Burston HE; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada., Brown KR; Donnelly Centre and Banting and Best Department of Medical Research, University of Toronto, Toronto, Canada., Rottapel R; Princess Margaret Cancer Centre, University Health Network, Toronto Medical Discovery Tower, University of Toronto, Toronto, Canada.; Department of Medicine, St. Michael's Hospital, Toronto, Canada.; Department of Medical Biophysics, St. Michael's Hospital, Toronto, Canada.; Department of Immunology, St. Michael's Hospital, Toronto, Canada.; Division of Rheumatology, St. Michael's Hospital, Toronto, Canada. |
| Source: | Oncotarget [Oncotarget] 2017 Jan 17; Vol. 8 (3), pp. 4484-4500. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Impact Journals Country of Publication: United States NLM ID: 101532965 Publication Model: Print Cited Medium: Internet ISSN: 1949-2553 (Electronic) Linking ISSN: 19492553 NLM ISO Abbreviation: Oncotarget Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
